Skip to main content
About / Daniel Drake Medal / Recent Medalists

Recent Daniel Drake Medalists

2023 Drake Medal Recipients

Linda Book
Linda S. Book, MD

Linda Book, MD, a 1971 graduate of the University of Cincinnati College of Medicine, is currently professor in the Department of Pediatrics at the University of Utah School of Medicine. She is the emerita chief of the Division of Pediatric Gastroenterology at the University of Utah and emerita director and co-founder of the Pediatric Liver Transplant Program and Liver Center at Primary Children’s Medical Center.

After receiving her medical degree, Dr. Book completed a pediatrics internship at Cincinnati Children’s and a pediatrics residency at the University of Utah. She then received fellowship training in pediatric gastroenterology, hepatology and nutrition and cystic fibrosis at the University of Utah. Dr. Book has been a member of the University of Utah faculty in the Department of Pediatrics since 1976, rising to professor in 2001.

A pioneer in pediatric gastroenterology and hepatology, Dr. Book has an extensive clinical practice at Primary Children’s Medical Center, where she cares for infants, children and adolescents with liver disease as well as those needing care before and after liver transplant.

Her research accomplishments include describing the endemic nature of necrotizing enterocolitis in premature infants, the utility of pH probe testing in pediatric gastroesophageal reflux, genetic and clinical associations in celiac disease and multicenter studies on cholestatic liver disorders. Her research in celiac disease resulted in her reporting on the high incidence of the disease in children with Down Syndrome. She also has researched breast milk nutritional composition, the epidemiology of biliary atresia and Clostridium difficile diarrhea in children.

Dr. Book received the American Academy of Pediatrics Utah Chapter Lifetime Achievement Award in 2020 and the chapter’s Marty Palmer Service to Children Award in 2008. She was named to the Cincinnati Children’s Hall of Honor in 2012 and, in 2009, was honored with the Murray Davidson Award, which recognizes clinical, teaching and research excellence in pediatric gastroenterology, by the American Academy of Pediatrics.

Dr. Book has held numerous national leadership positions in pediatric gastroenterology with the American Academy of Pediatrics (AAP), Society of Pediatric Liver Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). Among these were chair of NASPGHAN Women’s and Professional Development committees, council member for the Society for Liver Transplantation, president of the Utah Chapter of the American Academy of Pediatrics, United Network for Organ Sharing (UNOS) Pediatric Committee representative co-lead to improve care and allocation in liver transplantation, UNOS regional representative, and AAP Gastroenterology Section membership chair. She is currently active in global outreach efforts to Mongolia and Mexico to provide education and care to children with liver disease.

Image of Michael Farrell
Henry A. Nasrallah, MD

Henry A. Nasrallah, MD, is an emeritus professor of psychiatry, neurology and neuroscience and vice chair for faculty development in the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine. An internationally recognized psychiatrist, educator and researcher, Dr. Nasrallah’s expertise is in schizophrenia and his research focuses on the neurobiology and psychopharmacology of schizophrenia and psychotic mood disorders.

Dr. Nasrallah received his undergraduate and medical degrees from

the American University of Beirut. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the National Institutes of Health, he served as an assistant professor at the University of California, San Diego. He then became an associate professor and chief of psychiatry at the Veterans Affairs Medical Center at the University of Iowa. At age 38, he became chair of the Department of Psychiatry at The Ohio State University.

After serving as chair at Ohio State for 12 years, Dr. Nasrallah joined the faculty at the University of Mississippi. Four years later, he was recruited to the UC College of Medicine as associate dean for faculty mentorship. In 2013, Dr. Nasrallah became chair of the Department of Neurology and Psychiatry at the St. Louis University School of Medicine and held the Sydney Souers Endowed Chair. Dr. Nasrallah returned to the UC College of Medicine in 2019.

During his lengthy career, Dr. Nasrallah has published 460 scientific articles, 630 abstracts, 185 editorials and 13 books and currently is editor-in-chief of three peer-review journals. He is the founder of the Schizophrenia International Research Society, which holds an annual conference alternating between Europe and North America attended by more than 1,800 international researchers. He also established the CURESZ Foundation, which provides educational and advocacy services to families with a child suffering from schizophrenia.

Dr. Nasrallah and his wife, Amelia, an emerita faculty member at the UC College of Medicine, have established a dozen endowed lectureships and research and teaching awards for faculty, residents and medical students since 1998. Three of these support research and education at the UC Department of Psychiatry and Behavioral Neuroscience.

Earlier this year Dr. Nasrallah received the 2023 Stanley Dean Research Award from the American College of Psychiatrists for major contributions to the treatment of schizophrenia. He also has received the Golden Apple Teaching Award at four different medical schools, twice received the National Alliance for Mental Illness (NAMI) National Exemplary Psychiatrist Award and was recognized as the U.S. Teacher of the Year by The Psychiatric Times.

Bruce Giffin
Marc E. Rothenberg, MD, PhD
Marc E. Rothenberg, MD, PhD, has been an international thought leader in the allergy/immunology field for the past two decades. His research has contributed to understanding the mechanisms involved in eosinophilia and the translation of these findings to the development of precision therapy for allergic diseases, including a new class of drugs (anti-eosinophil therapeutics) that is transforming the care of patients with allergic diseases.

Dr. Rothenberg is a professor in the University of Cincinnati College of Medicine’s Department of Pediatrics and the director of the Allergy and Immunology Division at Cincinnati Children’s, where he holds the Bunning Chair of Allergy and Immunology. He is the founder and director of the Cincinnati Center for Eosinophilic Disorders and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), leading 16 institutions focused on eosinophilic diseases, in partnership with patient advocacy groups and the National Institutes of Health (NIH). Dr. Rothenberg has had a major role in describing a new set of diseases, eosinophilic gastrointestinal diseases, with the most common subtype being eosinophilic esophagitis. His research has elucidated the immunopathogenesis and genetics of this disease, and the approval of the first FDA-approved drug for eosinophilic esophagitis.

A member of the National Academy of Medicine, Dr. Rothenberg has received numerous prestigious national and international awards, including the 2007 E. Mead Johnson Award from the Society of Pediatric Research and an NIH MERIT Award in 2010, the 2023 Distinguished Scientist Award from the American Academy of Allergy, Asthma and Immunology, as well as the 2019 Paul Ehrlich Award from the International Eosinophil Society, a society for which he is the president-elect. He is Investigation, American Association of Physicians and the American Association for the Advancement of Science. Dr. Rothenberg has served a four-year term on the Advisory Council of the National Institute of Allergy and Infectious Diseases, where he advised Anthony Fauci, MD.

Dr. Rothenberg’s research has been supported by numerous sources including the NIH, Human Frontier Science Program Organization, Burroughs Wellcome Fund, Dana Foundation, U.S. Department of Defense, U.S.-Israel Binational Fund, the CURED Foundation, and the Patient Centered Outcome Research Institute. He has trained over 100 clinical and research investigators in his own laboratory and as program director and/or co-principal investigator of several NIH training grants.

Dr. Rothenberg received his undergraduate degree from Brandeis University, where he graduated summa cum laude in biochemistry and chemistry. He received his medical and doctoral degrees from Harvard Medical School, where he also completed his pediatric residency and allergy/immunology and hematology fellowships at Boston Children’s Hospital and the Dana Farber Cancer Institute. 


Bruce Giffin
Daniel Woo, MD

Daniel Woo, MD, is a leader in stroke research with significant contributions to the understanding of the epidemiology of stroke, particularly intracerebral hemorrhage (ICH).

A professor and vice chair of clinical research in the University of Cincinnati College of Medicine Department of Neurology and Rehabilitation Medicine, he has been during the last decade one of the highest funded researchers by the National Institute of Neurological Diseases. Among his important contributions was to establish that the impact of hypertension on ICH, which occurs in the cerebral lobes, was much less than previously thought and that risk factors for cerebral amyloid angiopathy (CAA) accounted for a much greater risk in lobar regions of the brain. CAA was once considered a rare cause of ICH, but Dr. Woo’s research showed that up to a third of all lobar ICHs may be caused by CAA, establishing it as a major mechanism of ICH.

Through his research, Dr. Woo led the first large-scale genomewide association study for ICH. His research also has had a specific focus for the disproportionate risk among African Americans and Hispanics, including identifying variation in the strength of traditional risk factors by race/ethnicity as well as by sex. This identification then replicated in multiple cerebral small vessel disease phenotypes and Dr. Woo’s research then performed deep sequencing, RNA sequencing and direct protein measurements to identify a potential novel risk factor for ICH as well as cerebral small vessel disease.

In addition, Dr. Woo has been evaluating stroke recovery with a particular focus on ICH. His research has demonstrated that a chronic inflammatory state may exist after ICH which can last for years after the stroke. If so, he hopes to identify a treatment that may reduce the inflammation and the long-term cognitive deficits associated with it. In addition to these additions to the ICH literature, Dr. Woo is leading a study on how advanced neuroimaging techniques may be able to predict recovery after ICH. By better defining the prediction of outcomes, patient selection for treatment studies, as well as identifying novel molecular targets for intervention, may be discovered.

Dr. Woo received his medical degree in 1994 and a master’s degree in molecular genetics in 2004 from the UC College of Medicine. He completed his residency in neurology at the Cleveland Clinic and then returned to the UC College of Medicine for a fellowship in cerebrovascular disorders. Dr. Woo joined the College of Medicine faculty in 1999. Since 2014, he has served as associate director of clinical research for the UC Gardner Neuroscience Institute and, from 2009 until 2019, he was the associate director of the UC Center for Environmental Genetics.

Dr. Woo has received numerous UC honors, including the Faculty Excellence Award (2020), Excellence Award for Faculty-to-Faculty Research Mentoring (2018) and the College of Medicine Research Service Award (2016). In 2004 he received the Robert G. Siekert American Heart Association New Investigator in Stroke Award.

Past Recipients

2023 Drake Medal Recipients

Linda S. Book, MD
Henry A. Nasrallah, MD
Marc E. Rothenberg, MD, PhD
Daniel Woo, MD

Expand all

2022 Drake Medal Recipients

Melanie T. Cushion, PhD
Michael K. Farrell, MD
Bruce F. Giffin, PhD

Expand all

2021 Drake Medal Recipients

William Barrett, MD
W. Brian Gibler, MD
Peter Stern, MD

Expand all

2020 Drake Medal Recipients

Alan Jobe, MD, PhD
Laura Wexler, MD

Expand all

Intranet Login

Contact Us

University of Cincinnati
College of Medicine

CARE/Crawley Building
Suite E-870
3230 Eden Avenue
PO Box 670555
Cincinnati, OH 45267-0555

Mail Location: 0555
Phone: 513-558-7333
Fax: 513-558-3512
Email: College of Medicine